Latest Content
UK rebate mechanism could force market withdrawals, warns BGMA
A UK rebate mechanism designed to increase access to new treatments and promote affordability “could actually be denying the NHS billions of pounds of annual savings due to the impact it is having on branded generics and biosimilars”, according to the BGMA.
Solifenacin surges as pharmacies hit by steep medicine price rises in April
Several different generics saw triple-digit-percentage price rises that led UK averages to as much as quadruple in April 2022, according to the latest figures from independent pharmaceutical pricing data service WaveData.